Chargement en cours...
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy
Combining immunotherapy with targeted therapy blocking oncogenic BRAF(V600) may result in improved treatments for advanced melanoma. Here, we developed a BRAF(V600E)-driven murine model of melanoma, SM1, which is syngeneic to fully immunocompetent mice. SM1 cells exposed to the BRAF inhibitor vemura...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
2012
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3422880/ https://ncbi.nlm.nih.gov/pubmed/22693252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-2837 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|